Information Provided By: 
Fly News Breaks for June 15, 2018
GBT
Jun 15, 2018 | 14:43 EDT
Janney Montgomery Scott analyst Yun Zhong called the weakness in shares of Global Blood Therapeutics an "over-reaction" the company's update at the EHA meeting, adding that he remains bullish on the HOPE Part A data. Zhong maintains a Buy rating on Global Blood shares, which are down nearly 15% to $40.20 in afternoon trading.
News For GBT From the Last 2 Days
There are no results for your query GBT
